BioNTech SE - 存託憑證(普通股)
US ˙ NasdaqGS ˙ US09075V1026

SecurityBNTX / BioNTech SE - Depositary Receipt (Common Stock)
InstitutionRYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity
Latest Disclosed Ownership983 shares
Latest Disclosed Value $ 104,660
RYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity reports 13.09% decrease in ownership of BNTX / BioNTech SE - Depositary Receipt (Common Stock)

On August 27, 2025 - RYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity filed a NPORT-P form disclosing ownership of 983 shares of BioNTech SE - Depositary Receipt (Common Stock) (US:BNTX) valued at $104,660 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 29, 2025 disclosing 1,131 shares of BioNTech SE - Depositary Receipt (Common Stock). This represents a change in shares of -13.09% during the quarter. The current value of the position is $88,067 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-27 2025-06-30 NP BioNTech SE EC US09075V1026 983 -148 -13.09 105 1.96 1.1631
2025-05-29 2025-03-31 NP BioNTech SE EC US09075V1026 1,131 234 26.09 103 0.00 1.0941
2025-03-03 2024-12-31 NP BioNTech SE EC US09075V1026 897 -299 -25.00 102 -28.17 1.0247
2024-11-29 2024-09-30 NP BioNTech SE EC US09075V1026 1,196 -20 -1.64 142 46.39 1.2866
2024-08-29 2024-06-30 NP BioNTech SE EC US09075V1026 1,216 -413 -25.35 98 -35.33 0.8909
2024-05-30 2024-03-31 NP BioNTech SE EC US09075V1026 1,629 281 20.85 150 5.63 1.2744
2024-02-29 2023-12-31 NP BioNTech SE EC US09075V1026 1,348 110 8.89 142 5.97 1.1660
2023-11-29 2023-09-30 NP BioNTech SE EC US09075V1026 1,238 -298 -19.40 134 -18.79 1.1645
2023-08-28 2023-06-30 NP BioNTech SE EC US09075V1026 1,536 211 15.92 166 0.00 1.3083
2023-05-30 2023-03-31 NP BioNTech SE EC US09075V1026 1,325 -57 -4.12 165 -20.29 1.2502
2023-02-28 2022-12-31 NP BioNTech SE EC US09075V1026 1,382 -232 -14.37 208 -4.61 1.2555
2022-11-29 2022-09-30 NP BioNTech SE EC US09075V1026 1,614 -121 -6.97 218 -15.89 1.5192
2022-08-29 2022-06-30 NP BioNTech SE EC US09075V1026 1,735 -333 -16.10 259 -26.70 1.7747
2022-05-26 2022-03-31 NP BioNTech SE EC US09075V1026 2,068 115 5.89 353 -30.02 2.0842
2022-02-28 2021-12-31 NP BioNTech SE EC US09075V1026 1,953 564 40.60 503 32.72 2.2248
2021-11-29 2021-09-30 NP BioNTech SE EC US09075V1026 1,389 -161 -10.39 379 9.22 1.5940
2021-08-27 2021-06-30 NP BioNTech SE EC US09075V1026 1,550 -1,497 -49.13 347 4.52 1.4534
2021-05-27 2021-03-31 NP BioNTech SE EC US09075V1026 3,047 -426 -12.27 333 17.31 1.4971
2021-03-01 2020-12-31 NP BioNTech SE EC US09075V1026 3,473 3,473 283 1.1530
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.